United States · Who invested in NeuroTherapeutics Pharma?
NeuroTherapeutics Pharma's investors include Novo Holdings, MPM Capital, SR One, Thomas, McNerney & Partners and GlaxoSmithKline.
200920102011
$3.2MDebt$43MSeries B$12MVentureUnited States · Venture startup
Who invested in NeuroTherapeutics Pharma
Funding summaryUpdated 26 Oct 2026
$58Mraised across 3 rounds since 2009, from 3 sources
$3.2MDebt$43MSeries B$12MVenture
- Latest round
- Venture, $12MDec 2011
- Biggest round
- $43MSeries B · May 2010
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Debt, $3.2M Jan 2009
- Biggest round
- $43M Series B · May 2010
- Usual gap between rounds
- 19 months the median of 2
The rounds
- Dec 2011Venture$12M
No investor was named in the report.
Reported by sec.govSEC filing: $12M sold, first sale Dec 2011
- May 2010Series B$43M5 new
Reported by fiercebiotech.comSEC filing: $19M sold, first sale May 2010
- Jan 2009Debt$3.2M
No investor was named in the report.
From a historical funding recordSEC filing: $3.2M sold, first sale Dec 2008
Founders and team
From the SEC filings it signed: 6 on the team.
- Brian B. WilliamsExecutive Officeri
- Holli A. CarlsonExecutive Officeri
- Michael P. VenutiExecutive Officeri
- Stephen D. CollinsExecutive Officer, Directori
- Stephen P. WanaskiExecutive Officeri
- Todd P. VerdoornExecutive Officeri
On the board, as filediCorey A. GoodmanElaine V. JonesHeath R. LukatchJason A. BrownLuke A. EvninRajeev R. DadooThomas R. Beck
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Debt2009Series B2010Venture2011
Novo Holdings
MPM Capital
SR One
Thomas, McNerney & Partners
GlaxoSmithKline
Novo HoldingsMPM CapitalSR OneThomas, McNerney & PartnersGlaxoSmithKlineEveryone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about NeuroTherapeutics Pharma
How much has NeuroTherapeutics Pharma raised?
NeuroTherapeutics Pharma has raised $58M across 3 rounds since 2009.
When did NeuroTherapeutics Pharma last raise?
NeuroTherapeutics Pharma's most recent round was a Venture of $12M in Dec 2011.
What was NeuroTherapeutics Pharma's biggest round?
NeuroTherapeutics Pharma's largest round on record is $43M (Series B), in May 2010.
Who backed NeuroTherapeutics Pharma first?
NeuroTherapeutics Pharma's first round on record, in May 2010, was backed by Novo Holdings, MPM Capital and SR One and 2 others.
What stage is NeuroTherapeutics Pharma at?
NeuroTherapeutics Pharma's latest named round is a Venture, in Dec 2011.
Where is NeuroTherapeutics Pharma based?
NeuroTherapeutics Pharma is based in the United States.
Companies like NeuroTherapeutics Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.